Trademark: XENAZINE 1320931
Word
XENAZINE
ID
1320931
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
16 September 2009
Registration Date
16 September 2009
Renewal Date
16 September 2029
Owner(s)
Service
Spruson & Ferguson
Goods and Services:
Class 5:
Pharmaceuticals; pharmaceutical preparations for the treatment of diseases, illnesses, disorders, ailments or conditions of the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; pharmaceutical preparations for the treatment of hyperkinetic movement disorders; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Huntington's disease; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of chorea; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Parkinson's disease; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of tourette syndrome; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of hemiballismus; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of tardive dyskinesia; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of amyotrophic lateral sclerosis; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of epilepsy; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of multiple sclerosis
Pharmaceuticals; pharmaceutical preparations for the treatment of diseases, illnesses, disorders, ailments or conditions of the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; pharmaceutical preparations for the treatment of hyperkinetic movement disorders; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Huntington's disease; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of chorea; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of Parkinson's disease; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of tourette syndrome; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of hemiballismus; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of tardive dyskinesia; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of amyotrophic lateral sclerosis; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of epilepsy; pharmaceutical preparations and substances for the prevention, treatment, and alleviation of multiple sclerosis